Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers

• Príomhchruthaitheoirí: Maria J. Arranz (Údar), Juliana Salazar (Údar), Valentin Bote (Údar), Alicia Artigas-Baleri (Údar), Alexandre Serra-LLovich (Údar), Emma Triviño (Údar), Jordi Roige (Údar), Carlos Lombardia (Údar), Martha Cancino (Údar), Marta Hernandez (Údar), Marc Cendros (Údar), Enric Duran-Tauleria (Údar), Natalia Maraver (Údar), Amaia Hervas (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2022-05-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of patients receive pharmacological treatment for comorbid symptoms. However, 30-50% do not respond adequa...